R&E tax credit bill
Like the Bush Administration's recent budget proposal for FY 1990, Sen. Danforth's (R-Mo.) Research & Experimentation bill would make permanent the 20% research and experimentation and basic research tax credits which are scheduled to expire at the end of 1989. Introduced March 15, S 570 also would make changes in the structure of the credit to increase its incentive effect on R&E spending and would extend credit benefits to startup firms to encourage "all taxpayers" to increase R&E spending, according to Danforth. Bill was referred to the Senate Finance Committee; no action scheduled to date.
You may also be interested in...
A new analysis of the ADAURA study shows that Tagrisso’s disease-free survival benefits in early stage EGFRm NSCLC are replicated for brain metastases, a common complication with a poor prognosis. Filings and OS data await.
FDA has heard from some manufacturers that additional time is needed to meet all of the requirements, “especially during the COVID-19 pandemic.” Prior to the pandemic, agency announced enforcement discretion during 2020 for compliance by firms with more than $10m in annual sales.
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.